The influence of liposomal adjuvant on intranasal vaccination of chickens against Newcastle disease

Veterinary Journal

Volumn 185, Issue 2, 2010, Pages 204-210

  Tseng, Li Ping ^a   Liang, Hong Jen ^b   Deng, Ming Chung ^c   Lee, Kuo Ming ^d   Pan, Ryh Nan ^e   Yang, Jen Chang ^d   Huang, Yi You ^a   Liu, Der Zen ^d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b YUANPEI UNIVERSITY   (Taiwan)

^c FISHERIES RESEARCH INSTITUTE   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e Taiwan Police College   (Taiwan)

Author keywords

Adjuvant; Intranasal; Liposome; Newcastle disease virus; S IgA

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOLOGICAL ADJUVANT; LIPOSOMAL ADJUVANT; NEWCASTLE DISEASE VACCINE; OCTADECYLAMINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; UNCLASSIFIED DRUG; LIPOSOME; VIRUS VACCINE;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; CHICKEN; CONTROLLED STUDY; DRUG FORMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION INHIBITION TEST; HUMORAL IMMUNITY; IMMUNOGENICITY; INOCULATION; LIPOSOMAL DELIVERY; NEWCASTLE DISEASE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NOSE MUCOSA; TRACHEOBRONCHIAL TOILET; VACCINATION; VIRUS STRAIN; ANIMAL; GERMFREE ANIMAL; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; NEWCASTLE DISEASE VIRUS; POULTRY DISEASES; VIRUS LOAD;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; CHICKENS; LIPOSOMES; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; POULTRY DISEASES; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRAL LOAD; VIRAL VACCINES;

ANIMALIA; GALLUS GALLUS; NEWCASTLE DISEASE VIRUS;

EID: 77953822476     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2009.05.019     Document Type: Article

References (43)

1. Akaki C., Shimazu M., Baba T., Tsuji S., Kodama H., Mukamoto M., Kajikawa T. Possible migration of Harderian gland immunoglobulin A bearing lymphocytes into the cecal tonsil in chickens. Journal of Veterinary Medicine Series B 1997, 44:199-206.
2. Alexander D.J. Newcastle Disease 1988, Khtwer Academic Publishers, London.
3. Alisky J.M., van de Wetering C.I., Davidson B.L. Widespread dispersal of cholera toxin subunit B to brain and spinal cord neurons following systemic delivery. Experimental Neurology 2002, 178:13-46.
4. Alving C.R. Liposomes as carriers of antigens and adjuvants. Journal of Immunological Methods 1991, 140:1-13.
5. Bakouche O., Gerlier D. Enhancement of immunogenicity of tumour virus antigen by liposomes: the effect of lipid composition. Immunology 1986, 58:507-513.
6. Beard C.W., Easterday B.C. The influence of route of administration of Newcastle disease virus on host response. I. Serological and virus isolation studies. Journal of Infectious Diseases 1967, 117:55-61.
7. Bedikian A.Y., Vardeleon A., Smith T., Campbell S., Namdari R. Pharmacokinetics and urinary excretion of vincristine sulfate liposomes injection in metastatic melanoma patients. Journal of Clinical Pharmacology 2006, 46:727-737.
8. Carr R.M., Lolachi C.M., Albaran R.G., Ridley D.M., Montgomery P.C., O'Sullivan N.L. Nasal-associated lymphoid tissue is an inductive site for rat tear IgA antibody responses. Immunological Investigations 1996, 25:387-396.
9. del Cacho E., Gallego M., Marcotegui M.A., Bascuas J.A. Follicular dendritic cell activation in the Harderian gland of the chicken. Veterinary Immunology and Immunopathology 1993, 35:339-351.
10. de Haan A., Geerligs H.J., Huchshorn J.P., van Scharrenburg G.J.M., Palache A.M., Wilschut J. Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunisation with an influenza subunit vaccine and coadministered liposomes. Vaccine 1995, 13:155-162.
11. de Lima M.C., Simões S., Pires P., Gaspar R., Slepushkin V., Düzgüneş N. Gene delivery mediated by cationic liposomes: from biophysical aspects to enhancement of transfection. Molecular Membrane Biology 1999, 16:103-109.
12. Fujihashi K., Koga T., van Ginkel F.W., Hagiwara Y., McGhee J.R. A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants. Vaccine 2002, 20:2431-2438.
13. Fukutome K., Watarai S., Mukamoto M., Kodama H. Intestinal mucosal immune response in chickens following intraocular immunisation with liposome-associated Salmonella enterica serovar enteritidis antigen. Developmental and Comparative Immunology 2001, 25:475-484.
14. Gabizon A., Isacson R., Libson E., Kaufman B., Uziely B., Catane R., Ben-Dor C.G., Rabello E., Cass Y., Peretz T. Clinical studies of liposome-encapsulated doxorubicin. Acta Oncologica 1994, 33:779-786.
15. Gregoriadis G. Immunological adjuvants: a role for liposomes. Immunology Today 1990, 11:89-97.
16. Gregoriadis G. Liposomes as immunological adjuvants: approaches to immunopotentiation including ligand-mediated targeting to macrophages. Research in Immunology 1992, 143:178-185.
17. Gregory R.L., Michalek S.M., Richardson G., Harmon C., Hilton T., McGhee J.R. Characterization of immune response to oral administration of Streptococcus sobrinus ribosomal preparations in liposomes. Infection and Immunity 1986, 54:780-786.
18. Hall M.A., Stroop S.D., Hu M.C., Walls M.A., Reddish M.A., Burt D.S., Lowell G.H., Dale J.B. Intranasal immunisation with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections. Infection and Immunity 2004, 72:2507-2512.
19. Hospenthal D.R., Rogers A.L., Mills G.L. Development of amphotericin B liposomes bearing antibody specific to Candida albicans. Mycopathologia 1988, 101:37-45.
20. Jansen T., Hofmans M.P., Theelen M.J., Manders F., Schijns V.E. Structure- and oil type-based efficacy of emulsion adjuvants. Vaccine 2006, 24:5400-5405.
21. Jayawardane G.W., Spradbrow P.B. Cell-mediated immunity in chickens vaccinated with the V4 strain of Newcastle disease virus. Veterinary Microbiology 1995, 46:37-41.
22. Kida H., Brown L.E., Webster R.G. Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus. Virology 1982, 122:38-47.
23. Latif N., Bachhawat B.K. The effect of surface charges of liposomes in immunopotentiation. Bioscience Reports 1984, 4:99-107.
24. Levine M.M., Kaper J.B., Black R.E., Clements M.L. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiological Reviews 1983, 47:510-550.
25. Li W., Watarai S., Iwasaki T., Kodama H. Suppression of Salmonella enterica serovar enteritidis excretion by intraocular vaccination with fimbriae proteins incorporated in liposomes. Developmental and Comparative Immunology 2004, 28:29-38.
26. Lin Y.M., Liu D.Z., Hawand H.M., Tseng L.P. Measurement of the second virial coefficient of DPPC and DPPG liposomes by isothermal titration calorimetry. Journal of the Chinese Institute of Chemical Engineers 2007, 38:103-106.
27. Mazumdar T., Anam K., Ali N. Influence of phospholipid composition on the adjuvanticity and protective efficacy of liposome-encapsulated Leishmania donovani antigens. Journal of Parasitology 2005, 91:269-274.
28. Michalek S.M., Eldridge J.H., Curtiss R., Rosenthal K.L. Antigen delivery systems: new approach to mucosal immunisation. Handbook of Mucosal Immunology 1994, 373-386. Academic Press, San Diego, USA. P.L. Ogra, J. Mestecky, M.E. Lamm, W. Strober, J. McGhee, J. Bienestock (Eds.).
29. Moghimi S.M., Patel H.M. Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes. FEBS Letters 1988, 233:143-147.
30. Mrsny R.J., Daugherty A.L., McKee M.L., FitzGerald D.J. Bacterial toxins as tools for mucosal vaccination. Drug Discovery Today 2002, 7:247-258.
31. Mutsch M., Zhou W., Rhodes P., Bopp M., Chen R.T., Linder T., Spyr C., Steffen R. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. New England Journal of Medicine 2004, 350:896-903.
32. Nakanishi T., Kunisawa J., Hayashi A., Tsutsumi Y., Kubo K., Nakagawa S. Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochemical and Biophysical Research Communications 1997, 240:793-797.
33. Raphael L., Tom B.H. Liposome facilitated xenogeneic approach for studying human colon cancer immunity: carrier and adjuvant effect of liposomes. Clinical and Experimental Immunology 1984, 55:1-13.
34. Reed L.J., Munch H. A simple method of estimating fifty percent end-points. The American Journal of Hygiene 1938, 27:493-497.
35. Sever J.L. Application of microtechnique to viral serological investigations. Journal of Immunology 1962, 88:320-329.
36. Tafaghodi M., Jaafari M.R., Sajadi Tabassi S.A. Nasal immunisation studies using liposomes loaded with tetanus toxoid and CpG-ODN. European Journal of Pharmaceutics and Biopharmaceutics 2006, 64:138-145.
37. Takada A., Kida H. Protective immune response of chickens against Newcastle disease, induced by the intranasal vaccination with inactivated virus. Veterinary Microbiology 1996, 50:17-25.
38. Tamura S., Samegai Y., Kurata H., Nagamine T., Aizawa C., Kurata T. Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine 1988, 6:409-413.
39. Tseng L.P., Liang H.J., Liu D.Z. Liposomes incorporated with cholesterol for drug release triggered by magnetic field. Journal of Medical and Biological Engineering 2007, 27:29-34.
40. Tsotas V.A., Mourtas S., Antimisiaris S.G. Dexamethasone incorporating liposomes: effect of lipid composition on drug trapping efficiency and vesicle stability. Drug Delivery 2007, 14:441-445.
41. Wang D., Christopher M.E., Nagata L.P., Zabielski M.A., Li H., Wong J.P., Samuel J. Intranasal immunisation with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses. Journal of Clinical Virology 2004, 31S:S99-S106.
42. Wong J.P., Stadnyk L.L., Saravolac E.G. Enhanced protection against respiratory influenza A infection in mice by liposome-encapsulated antibody. Immunology 1994, 81:280-284.
43. van Ginkel F.W., Jackson R.J., Yuki Y., McGhee J.W. Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. Journal of Immunology 2000, 165:4778-4782.